wound botulism

Also found in: Dictionary, Thesaurus, Encyclopedia.
Related to wound botulism: Infant botulism


1. any poisoning caused by Clostridium botulinum in the body; it produces a neurotoxin called botulinum toxin.
2. specifically, a rare but severe, often fatal, form of food poisoning due to ingestion of improperly canned or preserved foods contaminated with Clostridium botulinum. Called also foodborne botulism. Symptoms include vomiting, abdominal pain, headache, weakness, constipation, and nerve paralysis (causing difficulty in seeing, breathing, and swallowing), with death from paralysis of the respiratory organs. To prevent botulism, home canning and preserving of all nonacid foods (that is, all foods other than fruits and tomatoes) must be done according to proper specific directions.
Treatment. Treatment is determined based on the type of botulism, but careful respiratory assessment and support are always required. An antitoxin to block the action of toxin circulating in the blood can be used for foodborne and wound botulism if the problem is diagnosed and treated early.
foodborne botulism botulism (def. 2).
infant botulism that affecting infants, typically 4 to 26 weeks of age, marked by constipation, lethargy, hypotonia, and feeding difficulty; it may lead to respiratory insufficiency. It results from toxin produced in the gut by ingested organisms, rather than from preformed toxins.
wound botulism a form resulting from infection of a wound with Clostridium botulinum.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.

wound bot·u·lism

botulism resulting from infection of a wound.
Farlex Partner Medical Dictionary © Farlex 2012

wound bot·u·lism

(wūnd botyū-lizm)
Poisoning resulting from infection of a wound.
Medical Dictionary for the Health Professions and Nursing © Farlex 2012
References in periodicals archive ?
The total direct hospital costs for this outbreak was estimated at $2.3 million, for 203 total in-patient days charged at the historical median daily rate of $11,506 per day, based on data available for nine patients hospitalized with wound botulism in San Diego County during 2005-2016 (COSD, unpublished data; 2018).
Health alerts issued by COSD on October 9, 2017, and April 10, 2018, reminded health care providers to educate persons who inject drugs about the risks and symptoms of wound botulism, thoroughly search for wounds, consider a wound botulism diagnosis for patients with injection drug use history and cranial nerve abnormalities or descending paralysis, and consult promptly with local health departments to request BAT (1,2).
Botulism, a nationally notifiable condition, is a rare but serious illness of descending paralysis most commonly caused by the neurotoxin produced by the anaerobic, gram-positive bacteria Clostridium botulinum; wound botulism in particular results from germination of C.
With recent increases in opioid misuse nationwide (7) there is a growing need for awareness of the risks and symptoms of wound botulism among persons who inject drugs.
revealed that wound botulism occurs almost exclusively among drug users whose route is either subcutaneous or intramuscular as compared to intravascular route.
Making the diagnosis of wound botulism is a difficult but important task.
Hospital and ICU length of stay is another critical aspect of wound botulism. Increased ICU length of stay has been attributed to increased morbidity, mortality, and cost.
Wound botulism can be avoided with proper wound cleaning.
To our knowledge, this is the first outbreak of wound botulism in IDUs that was confirmed by molecular epidemiologic typing.
On October 5, the diagnosis of wound botulism was considered, and CDHS was consulted.
Editorial Note: Wound botulism, first described in association with traumatic injury, is a rare illness that occurs after spores of C.
However, it is unknown whether the increase in cases of wound botulism reflects increased supply of the drug, a change in its manufacture and distribution, or a change in drug-using behavior.